Evogenom Oy
Evogenom Oy's registered office is Jyväskylä. It is a limited company. The company was established on 2016-11-02. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2025-12-31, revenue was €135,759 and operating profit was -€442,533.
Trusted core data
Public company details from the trade register.
- Business ID
- 2786426-3
- Sector
- Research and experimental development on natural sciences and engineering
- Municipality
- Jyväskylä
- Company form
- Limited company
- Registration date
- 2016-11-02
- Business ID registration date
- 2016-10-06
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: Kauppakatu 39, 40100, Jyväskylä
Website: https://www.evogenom.comSource observation
About Evogenom Oy
Financial position and key figures for the company.
Evogenom Oy's location municipality is Jyväskylä. It is a limited company. The company was established on 2016-11-02. It operates in the industry of research and experimental development on natural sciences and engineering. In its latest retained statement for 2025-12-31, revenue was €135,759 and operating profit was -€442,533. The latest retained financial statement for 2025-12-31 shows revenue of €135,759 and profit for the financial year of -€448,558. Based on the latest retained statement, revenue growth was +26.8%, operating margin was -326.0%, and equity ratio was +42.5%.
Financial highlights
Key figures from the latest financial period.
2025-12-31
Financial ratios
Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
- Strong equity ratio
- Active registered status
- A newer financial statement filing has been reported
- Weak current ratio
- Negative profitability or net result
- Elevated industry distress context
- Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
- Evidence quality: Registry and statistical evidence → Usable financial evidence.
- Assessment confidence: Low → Medium.
- Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
- New risk factor: Sufficient structured financial metrics are not available.
The grade can use open digital financial statement data together with registry signals.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry context is elevated based on normalized open statistical inputs.
The company has about 9 years of registry continuity.
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Registry timeline
Trade register notifications shown on a timeline.
Financial statements availability
Available financial statement periods and PRH source filings.
Profile source and ownership
This company profile has not been claimed yet
Evogenom Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.